L-Propargylglycine
Need Assistance?
  • US & Canada:
    +
  • UK: +

L-Propargylglycine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

It is produced by the strain of Streptomyces sp. It can inactivate many vitamin B6-enzymes, such as Cystathionine γ-synthase, Methionone γ-lyase and L-alanine aminotransferase.

Category
L-Amino Acids
Catalog number
BAT-005604
CAS number
23235-01-0
Molecular Formula
C5H7NO2
Molecular Weight
113.11
L-Propargylglycine
IUPAC Name
(2S)-2-aminopent-4-ynoic acid
Synonyms
(S)-2-Aminopent-4-ynoic acid; (S)-2-Amino-4-pentynoic acid; L-2-Propynylglycine; (S)-Propargylglycine; (S)-2-Propargylglycine; L-Pra-OH; L-Propargyl-Gly-OH; 4-Pentynoic acid, 2-amino-, (2S)-; (2S)-2-Amino-4-pentynoic acid; 4-Pentynoic acid, 2-amino-, (S)-; 4-Pentynoic acid, 2-amino-, L-; (2S)-2-Azaniumylpent-4-ynoate; (S)-α-Propargylglycine; L-2-Amino-4-pentynoic acid
Related CAS
198774-27-5 (monohydrochloride)
Appearance
White powder
Purity
≥95%
Density
1.209±0.06 g/cm3
Melting Point
>200°C (dec.)
Boiling Point
272.1±35.0°C at 760 mmHg
Storage
Store at 2-8°C
Solubility
Soluble in Water
InChI
InChI=1S/C5H7NO2/c1-2-3-4(6)5(7)8/h1,4H,3,6H2,(H,7,8)/t4-/m0/s1
InChI Key
DGYHPLMPMRKMPD-BYPYZUCNSA-N
Canonical SMILES
C#CCC(C(=O)O)N
1. L-Cysteine enhances nutrient absorption via a cystathionine-β-synthase-derived H2 S pathway in rodent jejunum
Ailin Xiao, Jing Li, Tianjian Liu, Zhuxi Liu, Chuanfei Wei, Xiaomeng Xu, Qin Li, Jingxin Li Clin Exp Pharmacol Physiol. 2016 May;43(5):562-8. doi: 10.1111/1440-1681.12562.
Hydrogen sulphide (H2 S) is generated endogenously from L-cysteine (L-Cys) by the enzymes cystathionine-β-synthase (CBS) and cystathionine-γ-lyase (CSE). In addition, L-Cys is commonly used as a precursor in the food and pharmaceutical industries. The aim of the present study is to determine whether L-Cys regulates intestinal nutrient transport. To that end, the presence of CBS and CSE in the jejunum epithelium was assessed by immunohistochemistry, Western blotting and the methylene blue assay. In addition, in vivo L-Cys (100 mg/kg, administered immediately after the glucose load) significantly increased blood glucose levels 30 min after the oral administration of glucose to mice. This effect of L-Cys was completely blocked by amino-oxyacetic acid (AOA; 50 mg/kg; administered at the same time as L-Cys) an inhibitor of CBS. Measurements of the short-circuit current (Isc) in the rat jejunum epithelium revealed that L-Cys (1 mmol/L; 6 min before the administration of L-alanine) enhances Na(+)-coupled L-alanine or glucose transport, and that this effect is inhibited by AOA (1 mmol/L;10 min before the administration of L-Cys), but not D,L-propargylglycine (PAG;1 mmol/L; 10 min before the administration of L-Cys), a CSE inhibitor. Notably, L-Cys-evoked enhancement of nutrient transport was alleviated by glibenclamide (Gli;0.1 mmol/L; 10 min before the administration of L-Cys), a K(+) channel blocker. Together, the data indicate that L-Cys enhances jejunal nutrient transport, suggesting a new approach to future treatment of nutrition-related maladies, including a range of serious health consequences linked to undernutrition.
2. Propargylglycine-based antimicrobial compounds are targets of TolC-dependent efflux systems in Escherichia coli
Bec J Roldan, Andrea O Pajarillo, Jacob D Greenberg, Joyce E Karlinsey, Mauricio Cafiero, Elaine R Frawley, Larryn W Peterson Bioorg Med Chem Lett. 2020 Jan 15;30(2):126875. doi: 10.1016/j.bmcl.2019.126875. Epub 2019 Dec 4.
A library of novel l-propargylglycine-based compounds were designed and synthesized with the goal of inhibiting the growth of Gram-negative bacteria by targeting LpxC, a highly conserved Gram-negative enzyme which performs an essential step in the lipid A biosynthetic pathway. These compounds were designed with and without a nucleoside and had varying tail structures, which modulate their lipophilicity. The synthetic scheme was improved compared to previous methods: a methyl ester intermediate was converted to a hydroxamic acid, which obviated the need for a THP protecting group and improved the yields and purity of the final compounds. Antimicrobial activity was observed for non-nucleoside compounds containing a phenyl propargyl ether tail (5) or a biphenyl tail (6). An MIC of 16 µg/mL was achieved for 6 in Escherichia coli, but inhibition was only possible in the absence of TolC-mediated efflux. Compound 5 had an initial MIC >160 µg/mL in E. coli. Enhancing outer membrane permeability or eliminating efflux reduced the MIC modestly to 100 µg/mL and 80 µg/mL, respectively. These results highlight the importance of hydrophobicity of this class of compounds in developing LpxC inhibitors, as well as the design challenge of avoiding multidrug efflux activity.
3. The role of l-cysteine/Hydrogen sulfide pathway on β3-Adrenoceptor- induced relaxation in mouse gastric fundus
Elif Ozveren Adibelli, Fatma Aydinoglu, Nuran Ogulener Nitric Oxide. 2022 Feb 1;119:19-28. doi: 10.1016/j.niox.2021.12.004. Epub 2021 Dec 10.
In this study, we investigated the possible role of the l-cysteine/hydrogen sulfide pathway in β3-adrenoceptors-mediated relaxation in isolated mouse gastric fundus tissue. l-cysteine (endogenous H2S; 10-6-10-2 M), sodium hydrogen sulfide (NaHS; exogenous H2S; 10-6-10-3 M), selective β3-adrenoceptors agonist BRL 37344 (10-9-10-4 M) and non-selective β-adrenoceptor agonist isoprenaline (10-9-10-4 M) produced concentration-dependent relaxation in mouse gastric fundus. The non-selective β-adrenoceptors antagonist propranolol (10-6 M) inhibited the relaxant response to isoprenaline but not to BRL 37344. On the other hand, the selective β3-adrenoceptors antagonist SR 59230A (10-5 M) inhibited the relaxant responses to BRL 37344. In addition, cystathionine-gamma-lyase (CSE) inhibitor D,L-propargylglycine (PAG, 10-2 M), cystathionine-beta-synthase inhibitor (CBS) aminooxyacetic acid (AOAA, 10-2 M), and the combination of these inhibitors significantly reduced the relaxant responses induced by l-cysteine and BRL 37344. Pre-incubation of gastric fundal strips with propranolol (10-6 M) and SR 59230A (10-5 M) did not affect relaxations to l-cysteine and NaHS. Also, the existence of CSE, CBS, 3-mercaptopurivate sulfur transferase (3-MST) enzymes and β3-adrenoceptors were detected in gastric fundal tissue. Furthermore, basal H2S release was detected in the measurements. H2S level increased in the presence of l-cysteine, NaHS, and BRL 37344. The increase in H2S level by l-cysteine and BRL 37344 decreased significantly with PAG and AOAA enzyme inhibitors. These results suggest that endogenous H2S is synthesized from l-cysteine at least by CBS and CSE enzymes. Also, β3-adrenoceptors are found in the mouse stomach fundus and mediate BRL 37344-induced relaxations, and l-cysteine/hydrogen sulfide pathway plays a partial role in β3-adrenoceptors-mediated relaxation in mouse gastric fundus tissue.
Online Inquiry
Verification code
Inquiry Basket